MedPath

Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest

Not Applicable
Conditions
Cardiac Arrest
Registration Number
NCT02869997
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The aim of this study is to evaluate the prognostic value of the suppression ratio monitored by Bispectral Index for prediction of neurologic outcome after cardiac arrest. All patient admitted to our intensive care unit after a cardiac arrest are included. The results of the suppression ratio will be collected in the 6 first hours of admission. We will evaluate the link between suppression ratio and cerebral performance category score collected at three months.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Adult
  • Cardiac arrest admitted to the ICU
Exclusion Criteria
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Cerebral Performance Category score3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHRU Besançon

🇫🇷

Besançon, France

CHRU Besançon
🇫🇷Besançon, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.